Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Selling, general and administrative $ 2,164,560 $ 2,576,802 $ 6,081,362 $ 7,267,239
Research and development 1,624,766 1,278,922 4,749,217 1,278,922
Loss from operations (3,789,326) (3,855,724) (10,830,579) (8,546,161)
Other income (expense):        
Change in fair value of warrant liabilities 44,996 (335,317) 111,552 871,680
Interest and dividends, net 131,740 242,543
Other income (expense), net 176,736 (335,317) 354,095 871,680
Loss before income taxes (3,612,590) (4,191,041) (10,476,484) (7,674,481)
Provision for income taxes
Net loss from continuing operations (3,612,590) (4,191,041) (10,476,484) (7,674,481)
Net loss from discontinued operations, net of tax (395,089) (437,015) (1,144,283)
Net loss $ (3,612,590) $ (4,586,130) $ (10,913,499) $ (8,818,764)
Weighted-average common shares outstanding, basic and diluted (in Shares) 25,160,994 26,548,688 25,784,010 24,415,888
Basic and diluted loss per share from continuing operations (in Dollars per share) $ (0.14) $ (0.16) $ (0.41) $ (0.31)
Basic and diluted loss per share from discontinuing operations (in Dollars per share) $ 0 $ (0.01) $ (0.02) $ (0.05)
Comprehensive loss:        
Net loss $ (3,612,590) $ (4,586,130) $ (10,913,499) $ (8,818,764)
Foreign currency translation (4,256) (82,514) (7,056) (136,012)
Comprehensive loss $ (3,616,846) $ (4,668,644) $ (10,920,555) $ (8,954,776)